Clinical Trial Update: Naltrexone Treatment of Alcohol Abuse in Schizophrenia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessing naltrexone for alcohol use disorder in individuals with schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Schizophrenia

Drugs mentioned

• Naltrexone (Naltrexone)

Snippet

Sponsor: State University of New York - Upstate Medical University | Conditions: Schizophrenia, Mental Disorders | Phase 4 | Status: COMPLETED